Please login to the form below
Doina Ionescu elected to ABPI’s board of directors
Ionescu is managing director and general manager for Merck Healthcare UK and Ireland
The Association of the British Pharmaceutical Industry (ABPI) has elected Doina Ionescu, managing director and general manager for Merck Healthcare UK and Ireland, to its board of directors.
Ionescu will represent medium-sized companies on the ABPI board of directors, with aims of further strengthening the relationship between the pharma industry, patients, the NHS and the UK economy.
She began her career with Merck in 1998, working in R&D in Southampton. Since then, she has worked across various senior positions within the company including in corporate business development, life sciences and healthcare.
Prior to taking on the role of general manager for Merck Healthcare UK & ROI, she held the position of global head of business innovation.
“I feel privileged and delighted to have been elected onto the ABPI board of directors. If there was ever any doubt, last year has demonstrated the paramount importance of a strong, trusting and collaborative relationship between our industry and the wider health system,” said Ionescu.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- bluebird bio reveals plans to launch two gene therapies
- ONS data reveals significant decrease in COVID-19 antibodies
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- Eli Lilly to make bebtelovimab commercially available to US states from August
- ONS records a continued fall in UK COVID-19 infections
- Environment: where does the pharmaceutical industry stand?
- Moderna’s Omicron booster receives MHRA approval
- Lack of evidence for AstraZeneca’s COVID-19 vaccine says UK Department of Health
- NHS England outlines measures to boost capacity ahead of substantial winter pressures
- New research shows drug candidate may effectively treat antibiotic-resistant bacteria
- Sanofi and NIHR enrol first patient in immunisation study for RSV in infants
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- Moderna’s Omicron booster receives MHRA approval
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- How the Royal Society’s EiR programme can help to drive UK innovation
- bluebird bio reveals plans to launch two gene therapies
- Genital herpes vaccine candidate heads for human studies
PMHub
The Good Ideas Group
Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...
Latest intelligence
- Environment: where does the pharmaceutical industry stand?
- ...
- The communication challenge of helping he next generation to be healthier
- As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
- Are we losing sight of what the democratisation of healthcare really looks like?
- We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
